New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
07:23 EDTDNDN, SNSSSunesis appoints Joseph DePinto as Chief Commercial Officer
Sunesis Pharmaceuticals (SNSS) announced the appointment of Joseph DePinto to the newly created position of executive vice president and Chief Commercial Officer. Prior to joining Sunesis, DePinto was Executive Vice President, Global Commercial Operations at Dendreon (DNDN).
News For SNSS;DNDN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTSNSSSunesis upgraded at Roth Capital
Subscribe for More Information
06:06 EDTSNSSSunesis upgraded to Buy from Neutral at Roth Capital
Subscribe for More Information
December 10, 2014
10:00 EDTSNSSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTSNSSOn The Fly: Pre-market Movers
Subscribe for More Information
06:40 EDTSNSSSunesis upgraded to Buy from Hold at Cantor
Subscribe for More Information
December 8, 2014
13:34 EDTSNSSSunesis announces positive results from ongoing trial of Vosaroxin
Subscribe for More Information
12:40 EDTSNSSOn The Fly: Midday Wrap
Subscribe for More Information
09:29 EDTSNSSSunesis risk/reward attractive, says RBC Capital
RBC Capital believes that the EU could approve Sunesis' vosaroxin drug. The firm says that an EU approval would lift the stock by about 35%, and ir keeps a $3 price target and Sector Perform rating on the shares.
05:51 EDTSNSSSunesis to host conference call
Conference call to discuss results from the Phase 3 VALOR trial of vosaroxin and cytarabine will be held on December 9 at 1:30 pm. Webcast Link
December 7, 2014
16:42 EDTSNSSSunesis announces presentation of Phase 3 VALOR trial results
Subscribe for More Information
December 6, 2014
09:15 EDTSNSSSunesis to hold a meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use